Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations and Comprehensive Loss

v3.22.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Revenues:    
Total revenues $ 3,000,000 $ 10,000,000
Expenses:    
Research and development 34,325,000 30,139,000
General and administrative 22,795,000 23,779,000
Depreciation and amortization 3,250,000 4,586,000
Goodwill impairment charge 32,466,000
Licensed technology impairment charge 32,916,000
Total expenses 92,836,000 91,420,000
Loss from operations (89,836,000) (81,420,000)
Gain on settlement with licensor 6,743,000
PPP loan payable forgiveness income 1,758,000
Interest and miscellaneous income 69,000 1,301,000
Interest and other expense (3,670,000) (4,115,000)
Net loss $ (84,936,000) $ (84,234,000)
Basic and diluted loss per common share $ (0.86) $ (0.91)
Weighted average number of common shares outstanding – basic and diluted 98,441,911 92,663,574
Other comprehensive income/(loss):    
Change in unrealized gains/(losses) related to available-for-sale debt securities $ 9,000 $ (10,000)
Foreign currency translation adjustments (26,000)
Comprehensive loss (84,953,000) (84,244,000)
License and Other Revenues [Member]    
Revenues:    
Total revenues $ 3,000,000 $ 10,000,000